1

2006 CAP TODAY Article Index Note: This index does not cover the CAP TODAY “Marketplace” or “Abstracts” columns. AACC meetings From errors to computing and staffing, AACC show had it all, 10/06:72 AIDS/HIV/other bloodborne diseases Picking the right site for HIV testing, 11/06:1 Analyzer surveys (see Instrumentation/instrument surveys) Automation Automation to suit labs of all sizes, 3/06:58 In histology, Lean teams up with automation, 8/06:1 For mid-size labs, automated mix a good match, 8/06:66 How Pap test automation is playing out, 10/06:1 Blood centers set sights on full automation, 10/06:1 Billing Guarding against private health plan abuses, 8/06:12 Blood/coagulation/hematology Q&A: One pathologist reviews more than 70 percent of the hematology slides and makes a report—is this practice common and acceptable? 1/06:85 Q&A: Are finger-sticks or capillary blood-draw tubes appropriate for all chemistries or for general chemistry, therapeutic drug monitoring, or oncology? 2/06:90 Q&A: Have studies been done correlating the use of caloric supplements with patients who are on Coumadin? 4/06:75

2

Q&A: Can consuming a large quantity of soy prolong prothrombin time? 8/06:91 Blood banking/transfusion Q&A: What is the best way to ensure that patients receive the specialized blood components they need? 2/06:90 Q&A: What marker should laboratorians review in the absence of the crossmatch-to-transfusion ratio? 3/06:14 Blood centers set sights on full automation, 10/06:1 B-type natriuretic peptide One-two punch in evaluating PE risk, 11/06:1 Cancer Lung cancer breakthrough: EGFR assay, 1/06:1 Circulating tumor cell test shows clinical mettle, 5/06:1 Going head-to-head to boost lymph node numbers, 6/06:1 For tumor markers, hope springs eternal, 7/06:1 Are ASC-US rates reasonable? HPV test could answer that question, 7/06:80 BRCA: What we know now, 9/06:1 What microarrays say about lymphomas, 10/06:1 Q&A: How do you use CD20, CD79a, and PAX-5 for B-cell determination? 10/06:94 Q&A: How do you use CD20, CD79a, and PAX-5 for B-cell determination, and are there situations where one is especially useful, as in Hodgkin versus T-cell-rich B-cell lymphoma? 10/06:94 Raising the bar for HER2 results, 12/06:1 Logic takes a holiday in dual approval of EGFR test, Erbitux, 12/06:1 CAP ’06 What’s the use? CAP ’06 tackles the practical, 6/06:76 New officer, governors sworn in, 10/06:84

3

CAP news CLA revamp means speed, efficiency, 4/06:51 CAP programs/services (see also Q-Probes) Six CAP groups pitch into tough pathology issues, 4/06:5 Guarding against private health plan abuses, 8/06:12 Cloudy or clear? Best forecasts for urine cultures, 11/06:86 Same book, different page—handling critical values, 12/06:5 CAP publications In living color: new body fluids atlas, 10/06:52 Capitol Scan CAP asks for withdrawal of proposed units-of-service limits, 1/06:86 Improving public access to patented technologies, 1/06:86 New clinical lab codes—’06 payment levels in line with CAP advice, 1/06:86 Report out on waived testing ‘best practices’, 1/06:86 Weighing in on waived test guidance, 1/06:87 Mobilizing against MUEs, 3/06:105 ’92 reg overstates benefits of cytology proficiency testing, 4/06:78 CMS to make another stab at MUEs, 5/06:97 Estimated cut for ’07: 4.6%, 5/06:97 Cost-saving ideas released, 5/06:97 New ‘Unbelievable Edits’ list to be released in August, 6/06:96 Arizona No. 10 for direct billing legislation, 6/06:96 Sizing up views of licensure laws, 6/06:96 Medical liability bills fail in Senate, 6/06:97 CAP’s legislative, regulatory focus for ’06, 6/06:97 AMA adopts EGFR resolution, 7/06:128 CAP hosts state pathology leaders, 7/06:128 Clinical lab oversight, 7/06:128 Pathology excluded from January MUE implementation, 8/06:90 A permanent TC grandfather, 8/06:90

4

CLIAC’s cytology PT recommendations, 8/06:90 A direct billing law in Tennessee, 8/06:90 2007 proposed physician fee schedule, 9/06:106 Direct billing in Massachusetts, 9/06:108 New hope for a cytology PT alternative, 10/06:98 A possible permanent TC grandfather, 10/06:99 Call on congress to mend flawed SGR, 11/06:120 Asking NY officials to fix licensure regs, 11/06:120 What OIG will zero in on in ’07, 11/06:120 Pathology faces 11 percent cut in 2007, 12/06:74 Senator introduces bill to modify cytology PT, 12/06:74 MUEs now more manageable, 12/06:75 AMA, CAP to survey physician practices, 12/06:75 Cardiovascular disease/cardiac markers Looking high and low for cardiac markers, 4/06:1 hsCRP guidance no term of endearment, 8/06:1 Careers/employment Minding the business end of pathology, 8/06:1 Clostridium difficile C. difficile back with a vengeance, 5/06:1 Company consolidation (see Joint ventures/company consolidation) Company profiles/news Testing 1,2,3, 1/06:58 Why and how Hurley Medical Center chose co-ownership, 3/06:46 Off the flow charts: What users say about BD’s latest, 11/06:101 Competency assessment Recertification a good bet for all, 8/06:42

5

Competitive bidding Approaching zero hour for competitive lab bidding, 1/06:5 Core laboratories Lessons from three core curriculums, 7/06:1 CPT questions/coding Is CPT code 88360 appropriate for billing estrogen receptors by manual quantitative immunohistochemical analysis if the results are reported as 87 percent tumor cells staining? 1/06:86 Should I bill using CPT codes 88329 and 88333 if an intraoperative consultation with microscopic review of touch preparation is performed without a frozen section? 1/06:86 CMS and CERT contractor handling undercoded services, 5/06:97 Billing for frozen sections and squash preps, 5/06:97 For endocervical brushing specimens on a ThinPrep slide, can we process these as a nongynecologic specimen even though it is a cytology of a gynecological site? 7/06:128 Can our lab pass consultation charges to the patient or the patient’s insurance? 7/06:128 What is the proper code for a gallbladder submitted with a lymph node? 9/06:108 How do you code two specimens (right tube/ovary and left tube/ovary) from a positive test for the tumor-suppressor gene BRCA2? 9/06:108 Billing for outside consult services, 10/06:11 Should we use CPT code 88302 or 88304 for a foreskin removed for phimosis or hypospadius from an infant that is more than 30 days old? 11/06:121 What is the correct charge for a Cesarean-section scar excised from the wall of the abdomen? 11/06:121 C-reactive protein hsCRP guidance no term of endearment, 8/06:1

6

Critical values Critical thinking on critical values, 9/06:1 Cytopathology/histology (see also PAP/NGC Programs Review) 2005 regulatory PT results: What do they really mean? 5/06:48 Back to the beginning of the CET Consortium, 5/06:51 Are ASC-US rates reasonable? HPV test could answer that question, 7/06:80 In histology, Lean teams up with automation, 8/06:1 How Pap test automation is playing out, 10/06:1 Real simple—ASCCP guidelines set things straight, 11/06:5 Sticky business—using kits contrary to labeling, 11/06:64 D-dimer One-two punch in evaluating PE risk, 11/06:1 Diagnostic test kit Sticky business—using kits contrary to labeling, 11/06:64 Digital imaging Breaking the glass slide habit to make primary diagnoses, 4/06:1 Editorials of CAP president (see President’s Desk) EGFR (HER1) test Logic takes a holiday in dual approval of EGFR test, Erbitux, 12/06:1 Electronic health/medical records OK to donate select electronic record technology, 10/06:48 Firsthand Views The future of pay and peanut butter, 1/06:98 Merging Lean and ‘go home happy’, 2/06:102

7

Meeting and mental energy, 3/06:118 Your best-ever colleagues, 4/06:90 The power of listening, 5/06:110 Charting performance like a stock, 6/06:110 The Bad-Attitude Index, 7/06:138 The morale survey, 8/06:102 The many levels of logic, 9/06:126 Inspiring experimentation, 10/06:110 The experimentist, 11/06:134 Why it pays to pay more, 12/06:90 Flow cytometry Off the flow charts: What users say about BD’s latest, 11/06:101 Gene expression test Steering the straits of transplant testing, 6/06:1 Gene patents Gene patents—groups aim for nonexclusive arrangements, 9/06:85 Genetics Mutational wild cards—what do they mean? 4/06:1 Is there a place for race in medicine? 7/06:1 BRCA: What we know now, 9/06:1 Gene patents—groups aim for nonexclusive arrangements, 9/06:85 Glucose/insulin/blood sugars Nearing high tide on low blood sugars, 3/06:1 For glucoses, tight theory a tough practice, 11/06:1 Glycemic control Call to action on glycemic control, 3/06:90 A controlling interest in ICU blood sugars, 3/06:92 For glucoses, tight theory a tough practice, 11/06:1

8

HER2 Raising the bar for HER2 results, 12/06:1 Human papillomavirus Real simple—ASCCP guidelines set things straight, 11/06:5 Hurricane Katrina After Katrina, lessons from lab survivors, 2/06:1 Infection control C. difficile back with a vengeance, 5/06:1 Showing MRSA no mercy, 12/06:1 Information systems, technologies (see also Automation) Sifting through anatomic pathology system needs and wants, 1/06:18 Smooth operator in the lab: middleware, 2/06:1 Automation to suit labs of all sizes, 3/06:58 When POC connects the data, everyone wins, 4/06:20 Lab-link software vendors take stock of tomorrow, 5/06:12 The lowdown on choosing a lab-link vendor, 5/06:18 Plenty of solutions to shore up an aging LIS, 6/06:5 Middleware: A go-between gains ground in the lab, 6/06:62 Suit yourself: making patient ID technology fit, 7/06:108 Get your bearings before buying a blood bank system, 10/06:24 Hang on or move on? How to assess an LIS, 11/06:18 On a quest for a new LIS? Research, research, research, 11/06:24 Instrumentation/instrument surveys In coagulation market, no need to break the budget, 2/06:22 Collection the key, regardless of the route, 3/06:20 All the basics on 11 bedside glucose-testing systems, 4/06:26 For home or PC use, a variety of options (coag analyzers at the point of care, self monitoring), 5/06:70

9

Move to integrated analyzers well underway, 6/06:14 Chemistry analyzers—all that’s new and more, 7/06:14 Menu and other enhancements underway (chemistry analyzers for low-volume labs), 8/06:19 Blood gas vendors move forward on menu, convenience, stability, and more, 9/06:24 New QC, parameters, and automation for hematology analyzers, 12/06:12 Insulin (see Glucose/insulin/blood sugars) Joint ventures/company consolidation Why and how Hurley Medical Center chose co-ownership, 3/06:46 Adding up the lessons from consolidation, 5/06:1 Parsing Sonic’s buy of U.S. laboratory, 9/06:1 Lab automation Smooth operator in the lab: middleware, 2/06:1 Middleware: A go-between gains ground in the lab, 6/06:62 Lessons from three core curriculums, 7/06:1 Laboratory Accreditation News/CLA programs Reinforcing the safety net, 3/06:11 Surprise! Unannounced inspections not so bad, 4/06:46 Lab inspector training online; PT performance monitoring on tap, 8/06:57 Checklists undergoing more intensive review, 8/06:64 CAP fine-tunes unannounced inspection process, 12/06:55 Laboratory Accreditation News: Queries and Comments Why the term “commentary” in CAP checklist questions has been replaced with the word “note,” 4/06:46 Maintaining competence among personnel performing point-of-care testing, 4/06:46

10

Verifying the accuracy of automatic pipettes, 4/06:46 Using bar-coded labels on the glass slides in the anatomic pathology department, 4/06:46 How CAP checklists address noisy instruments in the lab, 8/06:57 Guidance for inspecting for questions TLC.10500 and TLC.10600 (the lab director’s role in lab management) in the new team leader checklist, 8/06:57 The necessity of validating the pneumatic tube system in a lab, 8/06:57 The necessity of revalidating rules of a lab’s autoverification process, 8/06:59 The necessity of a written contract to ensure that appropriate transfusion support is occurring, 12/06:55 Lean manufacturing principles Trimming the fat from lab processes, 5/06:42 In histology, Lean teams up with automation, 8/06:1 Legal issues (see also Medical mistakes) Expert witness guidelines: Pathologists given new order in the courtroom, 7/96:5 Clash act: peer review of expert witness testimony, 10/06:5 Sticky business—using kits contrary to labeling, 11/06:64 Letters Amyloidosis, 1/06:9 Pharyngeal culture of S. aureus, 1/06:12 HER2/neu, 1/06:14 Amyloidosis, 2/06:12 Professional component billing, 3/06:8 Amyloidosis, 3/06:12 Remembering Big Charity, 3/06:11 Middleware, 5/06:12 Articles as ads, 5/06:14

11

Laboratory error, 7/06:11 Proficiency testing and statistics, 7/06:11 Critical values, 8/06:6 Putting lab professionals in the spotlight, 8/06:11 Pay for lab professionals, 9/06:12 Specimen collection, 9/06:12 Billing for outside consult services, 10/06:11 Critical values, 10/06:14 Licensure, 11/06:8 Licensure in California, 11/06:8 Professional recognition, 11/06:8 Technologist training, 11/06:8 Students and salaries, 11/06:8 Assisting the pathologist, 11/06:8 Management issues/laboratory utilization Owning, rather than buying, reference lab services, 3/06:42 Why and how Hurley Medical Center chose co-ownership, 3/06:46 Lessons from three core curriculums, 7/06:1 Minding the business end of pathology, 8/06:1 Guarding against private health plan abuses, 8/06:12 Tapping the potential synergy of radiology, pathology, 9/06:58 Saving faces—selling your health system, your lab and the job, 12/06:38 Medical mistakes (see also Legal issues) Confusion about errors in anatomic pathology: problems with categorizing and reporting, 2/06:66 Medical unbelievable edits Unbelievable medically unbelievable edits, 2/06:11 Medicare (see also Medicare entries under Capitol Scan)

12

Approaching zero hour for competitive lab bidding, 01/06:5 Microbiology Physician with a vision has his eye on a chip, 3/06:4 C. difficile back with a vengeance, 5/06:1 Real-time PCR for the rest of us, 6/06:1 Middleware Smooth operator in the lab: middleware, 2/06:1 Middleware: A go-between gains ground in the lab, 6/06:62 Molecular diagnostics Straight talk on molecular reports, 1/06:1 Molecular testing in cytopathology, 2/06:56 The predictive assay puzzle, 3/06:1 Real-time PCR for the rest of us, 6/06:1 For tumor markers, hope springs eternal, 7/06:1 What microarrays say about lymphomas, 10/06:1 Myocardial infarction (see Cardiovascular disease/cardiac markers) Needlestick injuries Stick shift—new ideas in needle safety, 6/06:1 Newsbytes Nebraska working out kinks in statewide telehealth initiative, 1/06:88 Orchard introduces AP module, 1/06:88 Mediware, ThermoGenesis collaborate on system for cell therapy products, 1/06:88 Creative Computer Applications and StorComm complete merger, 1/06:88 Advanced synoptic reporting made easy, 2/06:92 ITC and MAS join forces, 2/06:92 Technidata SAS opens U.S. headquarters, 2/06:93

13

AssistMed acquires speech-recognition firm, 2/06:93 PracticeXpert sells transcription unit, 2/06:93 GE and Intermountain one step closer to patient-centric care, 3/06:106 Health care IT resources on AHRQ Web site, 3/06:106 Cell phones: the latest medical device, 3/06:106 HIMSS accepting applications for 2006 Davies Awards, 3/06:106 Add-on modules for billing/AR systems, 3/06:107 New Web domain identifies doctors at a glance, 4/06:76 Medicity acquires Park City Solutions’ iServices group, 4/06:76 Impac releases new version of PowerPath AP system, 4/06:76 Computer-assisted triage system for ERs, 4/06:77 Antek Healthware and Novovision forge interface agreement, 5/06:98 Technology for battling bioterrorism, 5/06:98 Public laboratory LOINC meeting, 5/06:98 Apply and ye may receive—a free LIS, 5/06:98 TheraDoc upgrades infection control product, 5/06:98 Disconnected electronic data-capture platform, 5/06:98 Orion Systems International changes name, opens U.S. office, 5/06:98 UCLA profits from wireless technology pilot program, 6/06:99 Thomson Micromedex collaborates with Geisenger, MercuryMD, 6/06:100 KliniTek offers Web-based lab outreach solution, 6/06:100 Sytec Health introduces wearable EMR for patients, 6/06:100 FasterCures launches Web site focused on biological materials, 6/06:100 How two vendors responded to one blood bank system crash, 7/06:126 Eclipsys to purchase Sysware, 7/06:126 Thomson acquires MercuryMD, 7/06:126 Antek releases updated version of LabDaq LIS, 7/06:126 Elsevier introduces online clinical decision support tool, 7/06:127 New laboratory interface management system, 7/06:127 Global Works Systems launches physician calendaring solution, 7/06:127

14

How two hospitals are using video technology to share interpreters, 8/06:88 Misys releases new version of laboratory information system, 8/06:88 Clarient to purchase Trestle Holdings, 8/06:88 Web-based anatomic pathology practice management system, 8/06:88 ASTM International endorses SNOMED CT, 8/06:88 Bio-Rad enhances quality control portal, 8/06:89 New digital software for educators, 8/06:89 No need to shop ’til you drop, thanks to Web-based EMR service, 9/06:110 A case for making toll-free border-free, 9/06:110 Olympus America acquires Bacus Laboratories, 9/06:111 Antek HealthWare and GE announce systems interface, 9/06:111 Federal regulations for health information technology updated, 9/06:111 IDM releases new version of blood donor system, 9/06:112 Fletcher-Flora offering new middleware solution, 9/06:112 SNOMED CT integrated in drug knowledge base, 9/06:112 DCL and OntoReason partner on SPL label translation and coding, 9/06:112 Pathologist tosses transcription to traffic in software, 10/06:96 Glucose monitoring part of the gig for new cell phone, 10/06:96 Health language launches SNOMED CT module, 10/06:98 Luminex, Smiths Detection get homeland security contract from government, 10/06:98 Public laboratory LOINC workshop and meeting, 10/06:98 CAP member to speak at Mediware meeting, 10/06:99 KLAS keeps score: evaluates 2006 LIS marketplace, 11/06:116 How HIMSS’ hurricane relief project has helped one medical center, 11/06:116 Answers to lab-related questions about FDA bar-code rule, 11/06:117 Finding an HIT consultant that’s worth your while, 12/06:76 Misys Healthcare Systems and mTuitive team up on cancer reporting, 12/06:76

15

Antek partners with provider of electronic health records, 12/06:76 Schuyler House enters electronic medical records marketplace, 12/06:76 Psyche Systems integrates scripting technology into product line, 12/06:76 Obituary William R. Dito, MD, 5/06:8 Outreach labs Interest is up in outreach labs, 3/06:1 Outreach keeps labs on their toes, 9/06:88 PAP/NGC Programs Review Molecular testing in cytopathology, 2/06:56 A difficult distinction, 2/06:61 How the CAP’s PT program works, 2/06:62 Q&A: A mixture of stains in nongyn mailings, 2/06:64 Confusion about errors in anatomic pathology: problems with categorizing and reporting, 2/06:66 2005 regulatory PT results: What do they really mean? 5/06:48 Are you seeing what’s there? 5/06:48 Back to the beginning of the CET Consortium, 5/06:51 Significance of benign endometrial cells in cervicovaginal smears, 5/06:53 On CAP’s Web site, so much at your fingertips, 5/06:54 A tale of two tests: cytology gyn screening and mammography, 9/06:67 Categorizing anal-rectal cytology challenges, 9/06:67 When and how to use CPT code 88172, 9/06:70 View rare cases, earn CME credits online, 9/06:70 Your oft-asked questions about CAP Pap proficiency testing, 9/06:72 Q&A: Proper use of 88333 and 88334 CPT codes, 9/06:74 An e-learning course for cytoprep staff, 9/06:76

16

Please tell it like it is, 9/06:76 Pap tests (see Cytopathology/histology) Pathologists’ assistants New help in understanding the ‘proper work’ of PAs, 9/06:5 Pathology reports Straight talk on molecular reports, 1/06:1 No resistance to standardizing pathology reports, 3/06:5 Patient ID systems Suit yourself: making patient ID technology fit, 7/06:108 Payment issues Approaching zero hour for competitive lab bidding, 1/06:5 Guarding against private health plan abuses, 8/06:12 Pediatric brain injury Inflicted pediatric traumatic brain injury and ß-APP IHC, 4/06:62 Pharmocogenetics Chip shot—psychiatry puts targeted test in play, 7/06:86 Point-of-care testing Pediatric POC—small patients but big benefits, 2/06:78 When POC connects the data, everyone wins, 4/06:20 Top-notch program makes her leader of the POC, 8/06:5 Q&A: What are the requirements for verifying the analytical measurement range for glucose meters on instruments? 8/06:91 President’s Desk An easier walk through cyberspace, 1/06:11 Unbelievable medically unbelievable edits, 2/06:11

17

Reinforcing the safety net, 3/06:11 Where strategy meets intuition, 4/06:11 Safety—asking the right questions, 5/06:11 Being grateful and giving back, 6/06:1 Easing the expert witness path, 7/06:11 Reading the water, 8/06:11 Good intentions, bad consequences, 8/06:11 HER2 collaboration a model for the future, 10/06:11 A reality-based approach to cytology PT, 11/06:11 Ask today for a freeze on the SGR cut, 12/06:11 Proficiency testing (see also Laboratory Accreditation News/CLA programs) How the CAP’s PT program works, 2/06:62 With PT samples, labs need to keep it to themselves, 1/06:46 Psychiatry/drug therapy Chip shot—psychiatry puts targeted test in play, 7/06:86 Pulmonary embolism One-two punch in evaluating PE risk, 11/06:1 Q&A Why are there so many published equations for calculating osmolality and is one equation best? (Kazmierczak), 1/06:84 One pathologist reviews more than 70 percent of the hematology slides and makes a report—is this practice common and acceptable? (Novak) 1/06:85 Are fingersticks or capillary blood-draw tubes appropriate for all chemistries or for general chemistry, therapeutic drug monitoring, or oncology? (Lo), 2/06:90 What is the best way to ensure that patients receive the specialized blood components they need? (AuBuchon) 2/06:90

18

What to use for the benchmark quality assurance marker in the blood bank (AuBuchon), 3/06:105 Using the six-hour urine creatinine panel to manage acute renal failure patients (Horowitz), 3/06:104 Is it critical that sodium fluoride tubes be used to collect specimens for lactate? (Kazmierczak), 5/06:96 How to comply with lab’s policy to call every critical value and when to report them to physicians (Yeransian), 5/06:96 Does Bouin fixation of biopsies cause false-negative IHC reactions with the lymphocytic markers? (Miller), 06/06:98 CAP AP checklist question ANP.22550 and cytology and histology blocks processed in formalin (Eisen and Fitzgibbons), 06/06:98 Is it possible to validate that the triglyceride/HDL ratio can be used as a surrogate marker for fasting insulin levels and is useful for monitoring the treatment of diabetics and assessing a patient’s cardiac risk? (Winter), 7/06:125 What are the requirements for verifying the analytical measurement range for glucose meters on instruments? (Schultz), 8/06:91 Are there guidelines for reporting the presence of sperm in routine urinalysis specimens? Or for pediatric patients? (Savage), 8/06:91 Can consuming a large quantity of soy prolong prothrombin time? (Krishman), 8/06:91 How to inform physicians that the BNP/NT-proBNP results may not accurately reflect left ventricular stretching/dysfunction in patients with renal disease (Apple and Johnson), 9/06:105 Who should monitor the POC testing performed in an ambulance? (Rose), 9/06:105 Should a microscopic urine exam be performed on a negative dipstick? (Haber), 9/06:105 What needs to be done to satisfy CAP requirements for test validation when processing nonvalidated sample types for clinical chemistry testing? (D’Agostino), 10/06:94 How do you use CD20, CD79a, and PAX-5 for B-cell determination? (Dorfman), 10/06:94

19

Is it acceptable to do a batch sign-out of surgical pathology reports in an anatomic pathology system? The pathologist who hand signs the reports would like to electronically sign out batches. Does this jeopardize patient safety and raise legal issues for the hospital? (Weiner, Gruber, Aller) 11/06:119 What are the best tests to assess the risk of developing acute renal failure from myoglobin in the kidney after rhabdomyolysis? (Wilkinson), 11/06:119 What values for hematology should have delta checks to prevent preanalytical errors? (Kroft), 12/06:78 What career opportunities—pathology related or other—are possible for the pathologist who no longer wants to deal with the medicolegal consequences of diagnostic work? (Gaffey), 12/06:78 Q-Probes Are ASC-US rates reasonable? HPV test could answer that question, 7/06:80 Cloudy or clear? Best forecasts for urine cultures, 11/06:86 Same book, different page—handling critical values, 12/06:5 Race/ethnicity Is there a place for race in medicine? 7/06:1 Reference lab services Owning, rather than buying, reference lab services, 3/06:42 Screening tests Pediatric POC—small patients but big benefits, 2/06:78 Steering the straits of transplant testing, 6/06:1 Picking the right site for HIV testing, 11/06:1 One-two punch in evaluating PE risk, 11/06:1 Self-testing (see Point-of-care testing)

20

Staffing shortages Saving faces—selling your health system, your lab and the job, 12/06:38 System review series (see Information systems) Telepathology Into the telepathology trenches at Henry Ford, 5/06:5 Test development Testing 1,2,3, 1/06:58 Test management Going head-to-head to boost lymph node numbers, 6/06:1 Tissue banking Order patrol—how to rein in test requests, 1/06:1 Tumor markers For tumor markers, hope springs eternal, 7/06:1 Transplantation Steering the straits of transplant testing, 6/06:1 Unannounced inspections Surprise! Unannounced inspections not so bad, 4/06:46 Urinalysis Q&A: Are there guidelines for reporting the presence of sperm in routine urinalysis specimens? Or for pediatric patients? 8/06:91 Q&A: Should a microscopic urine exam be performed on a negative dipstick? 9/06:10 Cloudy or clear? Best forecasts for urine cultures, 11/06:86

21

World Wide Web/blogging My not-so-secret life as a pathology and lab medicine blogger, 7/06:66